NCT01752842View on ClinicalTrials.gov

Lipid Biomarkers for Diabetic Heart Disease

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

February 23, 2018

Study Completion Date

February 23, 2018

Conditions
Type II Diabetes MellitusDiabetes Complications
Interventions
DRUG

Fenofibrate

DRUG

Placebo for fenofibrate

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Leducq Foundation
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Leducq Foundation

OTHER

lead

Washington University School of Medicine

OTHER

NCT01752842 - Lipid Biomarkers for Diabetic Heart Disease | Biotech Hunter | Biotech Hunter